Herpetic Keratitis

Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57(5):448-62.

Azher TN, Yin XT, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol. 2017;11:185-91.

Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.

Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976–2007: the effect of oral antiviral prophylaxis. Ophthalmology. 2010;117(1):37-42.

Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Arch Ophthalmol. 1998;116(12):1490-8.

Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Arch Ophthalmol. 2001;119(4):587-93.

Lee YJ, Kim SJ, Lee H, Park KH, Hwang JM. Reactivation of herpes simplex keratitis after COVID-19 vaccination. Cornea. 2021;40(10):1231-4.

Heldwein EE, Krummenacher C. Entry of herpesviruses into mammalian cells. Nat Rev Microbiol. 2008;6(10):750-60.

Hakki M, Chou S, Singh J, Shukla D. Virion host shutoff (vhs) protein: a critical determinant of herpes simplex virus pathogenesis. J Virol. 2020;94(8):e01822-19.

Zhang X, Azhar J, Newman C, Wang C, Shen L, Jin L, et al. Immune mechanisms in herpetic stromal keratitis: insights from animal models. Prog Retin Eye Res. 2017;60:28-49.

Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of interleukin-17 in the pathogenesis of herpetic stromal keratitis. J Immunol. 2019;203(3):657-66.

Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. Front Immunol. 2016;7:38.

Al-Dujaili LJ, Clerkin PP, Clement C, McFerrin HE, Bhattacharjee PS, Varnell ED, et al. Ocular herpes simplex virus: disease features, pathogenesis, and emerging therapies. Eye (Lond). 2021;35(7):1899-905.

Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Ophthalmology. 2010;117(5):914-9.

Patel DV, McGhee CN. In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review. Eye (Lond). 2018;32(2):233-51.

Cho KS, Kim SJ, Park SJ, Woo SJ. Diagnostic value of real-time PCR for herpes simplex virus in atypical epithelial keratitis. Exp Eye Res. 2019;186:107718.

Itokawa T, Okumura N, Kinoshita S, Koizumi N. Multiplex polymerase chain reaction for simultaneous detection of herpes simplex virus, varicella-zoster virus, cytomegalovirus, and adenovirus in ocular samples. Jpn J Ophthalmol. 2014;58(5):420-6.

Doan T, Wilson MR, Crawford ED, Chow ED, Khan LM, Knopp KA, et al. Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens. JAMA Ophthalmol. 2016;134(11):1190-7.

Suryawanshi A, Veiga-Pedrosa C, Rouse BT. Understanding the role of Th17 cells in herpetic stromal keratitis. Front Immunol. 2019;10:512.

Colin J, Hoh HB, Easty DL, Herbort CP, Aylward GW, Mills K, et al. Ganciclovir ophthalmic gel in the treatment of acute herpetic keratitis: results of a European multicenter randomized controlled trial. Ophthalmology. 2010;117(4):706-12.

Araki-Sasaki K, Ueta M, Tokuda S, Sonoda KH. Clinical efficacy of topical cyclosporine A for herpes simplex stromal keratitis. Cornea. 2014;33(12):1210-5.

Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. N Engl J Med. 2018;378(21):206-16.

Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Ophthalmology. 2015;122(8):1561-5.

Kaufman HE, Azcuy AM, Varnell ED, Thompson HW, Hill JM. HSV keratitis: pathogenesis and current therapy. Expert Opin Pharmacother. 2020;21(9):1025-33.

Dropulic LK, Cohen JI. The challenge of developing a herpes simplex virus vaccine. Front Microbiol. 2020;11:1490.

Maresova K, Liskova P, Hrdlickova E, et al. Bilateral herpes simplex keratitis in immunocompromised patients: a case series. Ophthalmol Ther. 2020;9(4):877-85.

Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2010;(12):CD002898.

World Health Organization. World report on vision. Geneva: WHO; 2019.